MedMira Inc.

Equities

MIR

CA58501R1029

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 03:30:29 2024-05-17 pm EDT			5-day change	1st Jan Change
0.095 ^CAD	+5.56%		0.00%	-13.64%

Apr. 02	MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
Mar. 27	Samsung Pay to stop working with Russia's Mir payment system from April 3	RE

MedMira Inc. Nominates Michael Sidler to its Board of Directors

September 26, 2012 at 05:21 pm EDT

MedMira Inc. announced that its controlling shareholder, Andurja Beteiligungen AG has changed its name to OnSite Lab Holding AG (OnSite Lab). Dr. Michael Sidler has been nominated as the board representative for OnSite Lab on MedMira's Board of Directors.

Latest news about MedMira Inc.

MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	Apr. 01	CI
Samsung Pay to stop working with Russia's Mir payment system from April 3	Mar. 27	RE
MedMira Says Received Canadian Patent for its Quantitative Diagnostic System	Mar. 13	MT
MedMira Brief: Says Received Canadian Patent for its Quantitative Diagnostic System	Mar. 13	MT
MedMira's Fiscal Q1 Loss Widens, Revenue Drops	Jan. 02	MT
MedMira Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	Dec. 28	CI
U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test	Dec. 13	CI
MedMira Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	Nov. 27	CI
Medmira Inc. Provides Update on Its Progress to Achieve Regulatory Approval in Canada and the USA for Its Infectious Disease Rapid Tests	23-09-27	CI
MedMira's Fiscal Q3 Loss Widens, Revenue Falls	23-06-30	MT
MedMira Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-28	CI
MedMira Falls Near 17% As Widens Q2 Net Loss YOY	23-04-04	MT
MedMira Widens Q2 Net Loss YOY	23-04-04	MT
MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-04-02	CI
MedMira Inc. Provides an Update on Its Progress to Achieve Regulatory Approval in Canada for Its Reveal TP Antibody Test	23-03-14	CI
MedMira Enters into Partnership with Maternova for USA and Latin America	23-02-21	MT
Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis	23-02-20	CI
MedMira Provides Progress Update	23-01-04	MT
MedMira Reports Wider Fiscal Q1 Loss, Lower Revenue	23-01-03	MT
MedMira Introduces New Product In Direct Response to Rise of Respiratory Syncytial Virus Cases Globally	22-12-30	MT
MedMira Inc. Introduces VYRA TriDemic	22-12-29	CI
MedMira Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022	22-12-29	CI
MedMira Inc. Auditor Raises 'Going Concern' Doubt	22-11-28	CI
MedMira Inc. Reports Earnings Results for the Full Year Ended July 31, 2022	22-11-28	CI
MedMira Inc. Appoints Sam Ratnam as Director of Scientific & Regulatory Affairs	22-10-02	CI

Chart MedMira Inc.

Duration

Period

More charts

Company Profile

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-27 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
MEDMIRA INC.	-13.64%	48.98M
THERMO FISHER SCIENTIFIC	+11.91%	227B
DANAHER CORPORATION	+15.46%	198B
INTUITIVE SURGICAL, INC.	+18.58%	142B
BOSTON SCIENTIFIC CORPORATION	+30.36%	111B
SIEMENS HEALTHINEERS AG	+0.65%	64.16B
EDWARDS LIFESCIENCES CORPORATION	+17.74%	54.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+5.82%	51.41B
AGILENT TECHNOLOGIES, INC.	+11.23%	45.32B
GE HEALTHCARE TECHNOLOGIES INC.	+5.73%	37.32B

Other Advanced Medical Equipment & Technology